Anticoagulant molecules

Anticoagulant molecules comprise a diverse class of agents that inhibit blood coagulation by acting on various components of the clotting cascade. Rather than a single molecular target, anticoagulants include vitamin K antagonists (e.g., warfarin), heparins (unfractionated and low molecular weight), and direct oral anticoagulants (DOACs) that target specific enzymes like thrombin or factor Xa. These drugs are used to prevent and treat thrombotic conditions such as deep vein thrombosis, pulmonary embolism, stroke related to atrial fibrillation, and to protect patients with mechanical heart valves. Their use is associated with an increased risk of bleeding and sometimes requires regular monitoring or dose adjustments based on renal function. Some anticoagulants interact significantly with foods and other drugs, necessitating careful management in clinical use[1][2][3][5][7].

Other names

Blood thinnersAntithrombotic agents

Inhibition of vitamin K-dependent clotting factor synthesis (e.g., warfarin)[2][3] - Direct inhibition of thrombin (factor IIa) (e.g., dabigatran, bivalirudin)[2][3][5] - Direct inhibition of factor Xa (e.g., rivaroxaban, apixaban, edoxaban, fondaparinux)[2][3][5] - Binding and potentiation of antithrombin III (heparins)[3] - Reduced fibrin formation[7]